» Articles » PMID: 22693531

Classification of Traditional Chinese Medicine Syndromes in Patients with Chronic Hepatitis B by SELDI-Based ProteinChip Analysis

Overview
Date 2012 Jun 14
PMID 22693531
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Traditional Chinese medicine (TCM) syndrome, also called ZHENG, is the basis concept of TCM theory. It plays an important role in TCM practice. There are excess and deficiency syndromes in TCM syndrome. They are the common syndromes in chronic hepatitis B (CHB) patients. Here we aim to explore serum protein profiles and potential biomarkers for classification of TCM syndromes in CHB patients. 24 healthy controls and two cohorts of CHB patients of excess syndrome (n = 25) or deficiency syndrome (n = 19) were involved in this study. Protein profiles were obtained by surface-enhanced laser desorption ionization time-flight mass spectrometry (SELDI-TOF/MS) and multiple analyses were performed. Based on SELDI ProteinChip data, healthy controls and CHB patients or excess and deficiency syndromes in CHB patients were obviously differentiated by orthogonal partial least square (OPLS) analysis. Two significant serum proteins (m/z 4187 and m/z 5032) for classifying excess and deficiency syndromes were found. Moreover, the area under the receiver operating characteristic (ROC) curve was 0.887 for classifying excess and nonexcess syndrome, and 0.700 for classifying deficiency and nondeficiency syndrome, respectively. Therefore, the present study provided the possibility of TCM syndrome classification in CHB patients using a universally acceptable scientific approach.

Citing Articles

Chronic hepatitis B: dynamic change in Traditional Chinese Medicine syndrome by dynamic network biomarkers.

Lu Y, Fang Z, Zeng T, Li M, Chen Q, Zhang H Chin Med. 2019; 14:52.

PMID: 31768187 PMC: 6873721. DOI: 10.1186/s13020-019-0275-4.


Indicators of Male Gout Patients' Comorbidities with the Theory on Traditional Chinese Medicine.

Zhang J, Zhang S, Xie J, Tang L, Qiu X, Xiao Y Evid Based Complement Alternat Med. 2019; 2018:9679213.

PMID: 30622620 PMC: 6304596. DOI: 10.1155/2018/9679213.


Characteristic proteins in the plasma of postoperative colorectal and liver cancer patients with Yin deficiency of liver-kidney syndrome.

Ji Q, Wang W, Luo Y, Cai F, Lu Y, Deng W Oncotarget. 2017; 8(61):103223-103235.

PMID: 29262557 PMC: 5732723. DOI: 10.18632/oncotarget.21735.


A metabolic mechanism analysis of Fuzheng-Huayu formula for improving liver cirrhosis with traditional Chinese medicine syndromes.

Song Y, Chen J, Cai F, Lu Y, Chen Q, Zhang Y Acta Pharmacol Sin. 2017; 39(6):942-951.

PMID: 29072258 PMC: 6256279. DOI: 10.1038/aps.2017.101.


Metabolomic mechanisms of gypenoside against liver fibrosis in rats: An integrative analysis of proteomics and metabolomics data.

Song Y, Dong S, Wei B, Liu P, Zhang Y, Su S PLoS One. 2017; 12(3):e0173598.

PMID: 28291813 PMC: 5349658. DOI: 10.1371/journal.pone.0173598.


References
1.
Fujita N, Nakanishi M, Mukai J, Naito Y, Ichida T, Kaito M . Identification of treatment efficacy-related host factors in chronic hepatitis C by ProteinChip serum analysis. Mol Med. 2010; 17(1-2):70-8. PMC: 3022982. DOI: 10.2119/molmed.2010.00124. View

2.
Cui J, Liu Y, Zhou H, Kang X, Huang C, He Y . Screening serum hepatocellular carcinoma-associated proteins by SELDI-based protein spectrum analysis. World J Gastroenterol. 2008; 14(8):1257-62. PMC: 2690676. DOI: 10.3748/wjg.14.1257. View

3.
Wang B . Treatment of chronic liver diseases with traditional Chinese medicine. J Gastroenterol Hepatol. 2000; 15 Suppl:E67-70. DOI: 10.1046/j.1440-1746.2000.02100.x. View

4.
Lavanchy D . Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J Clin Virol. 2006; 34 Suppl 1:S1-3. DOI: 10.1016/s1386-6532(05)00384-7. View

5.
Zuberovic A, Wetterhall M, Hanrieder J, Bergquist J . CE MALDI-TOF/TOF MS for multiplexed quantification of proteins in human ventricular cerebrospinal fluid. Electrophoresis. 2009; 30(10):1836-43. DOI: 10.1002/elps.200800714. View